Morgan Stanley’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
2023
Q3
$2.77K Sell
2023
Q2
$554K Sell
2023
Q1
$1.21M Sell
2022
Q4
$1.23M Sell
2022
Q3
$2.46M Sell
2022
Q2
$1.66M Sell
2022
Q1
$2.15M Sell
2021
Q4
$1.48M Sell
2021
Q3
$4.2M Sell
2021
Q2
$5.02M Sell
2021
Q1
$6.29M Buy
2020
Q4
$5.11M Buy
2020
Q3
$1.42M Buy
2020
Q2
$124K Buy
2020
Q1
$57K Sell
2019
Q4
$639K Buy
2019
Q3
$164K Buy
2019
Q2
$119K Sell
2019
Q1
$182K Buy
2018
Q4
$185K Buy